Ozempic Slows Kidney Disease, Novo Nordisk Study Finds 
 

Novo Nordisk's Ozempic drug slows the progression of chronic kidney disease and cuts the risk of kidney failure, heart attack, stroke and death in patients with Type 2 diabetes, a long-term trial showed.


 
Lucid Group Is Cutting 6% of Its Workforce. The Stock Is Up. 
 

The electric-vehicle start-up says the job cuts are part of a restructuring plan to optimize its operating expenses.


 
Sony's Entertainment Unit Syncs Up for Success, Paramount or Not 
 

Sony is aiming to make better use of intellectual property across gaming, films and more.


 
Nvidia Stock Gains. What's Left of the Bear Case Against the Chip Maker. 
 

The few headwinds currently facing Nvidia appear to emanate from China.


 
Why T.J. Maxx and Ross Stores Shares Command Full Price 
 

Off-price retailers TJX Cos. and Ross Stores have piles of deals for bargain hunters. Their stocks are a different story.


 
U.S. Real-Estate Fund Details Limits to Investor Redemptions 
 

Starwood Real Estate Income Trust is tightening its redemption policies for investors as it slows its real-estate asset sales amid depressed prices.


 
Jeep and Ram Dealers Gripe to Stellantis as Cars Sit on Lots 
 

The automaker is cutting prices and launching an unusual incentive program following a meeting with retailers.


 
E.l.f. Beauty Boosts Marketing Budget to 25% of Net Sales 
 

The cosmetics company has ramped up spending for one simple reason: "Our marketing investment is working."


 
Elon Musk denies report SpaceX may sell some of its shares amid $200 billion valuation 
 

The aerospace company has "no need for additional capacity" and will buy back shares, said SpaceX CEO and founder Elon Musk.


 
Intuit warns of fewer TurboTax users who file for free. It says it's not interested in them anyway. 
 

Intuit Inc., the tech company behind TurboTax filing software and the personal-finance site Credit Karma, raised its full-fiscal-year profit and sales outlook on Thursday, following third-quarter results that topped Wall Street's expectations.


(END) Dow Jones Newswires

05-24-24 0915ET